Juxtapid Capsule
Product Images NDC 10122-405

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Juxtapid (NDC 10122-405). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Chiesi Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Juxtapid 01)

Chemical structure of lomitapide mesylate, the active ingredient in Juxtapid capsules. The diagram shows the molecular arrangement including aromatic rings, nitrogen atoms, and trifluoromethyl groups characteristic of this compound.*

FDA Label Image

Figure 1 (Juxtapid 02)

A line graph showing the mean percentage change in direct LDL-C from baseline over 26 weeks of treatment with varying mean doses (5 mg to 45 mg). The graph includes two data series: Week 26 completers (N=29) represented by filled circles, and Week 26 LOCF (N=23) represented by open circles. The x-axis shows weeks, and the y-axis shows percent change, with values descending to about -60%. Error bars indicate variability for each data point.*

FDA Label Image

Figure 2 (Juxtapid 03)

A line graph showing mean percentage change from baseline (with standard deviation error bars) over time in weeks, ranging from 4 to 24 weeks. The y-axis represents mean percentage change from baseline, while the x-axis represents time in weeks relative to baseline. The sample size at each time point is indicated below the x-axis, with values between 33 and 42 subjects.*

FDA Label Image

Principal Display Panel (2 mg Capsule Bottle Label)

Juxtapid (lomitapide) capsules 2 mg label displaying storage conditions and capsule count of 28. The label includes the NDC 10122-402-28, manufacturer Chiesi Farmaceutici S.p.A., Parma, Italy, and states the product is prescription only with dosage information referring to the prescribing information. The label also shows a barcode and placeholders for lot and expiry numbers.*

FDA Label Image

Principal Display Panel (2 mg Capsule Bottle Carton)

Juxtapid 2 mg (lomitapide) capsules packaging label for a 28-capsule bottle. The label includes storage instructions, dosage note to see prescribing information, and the active ingredient lomitapide. The labeler is Chiesi, manufactured for Chiesi Farmaceutici S.p.A., Parma, Italy. The NDC 10122-402-28 is shown with Rx Only designation.*

FDA Label Image

5 mg Bottle Label (Juxtapid 06)

Juxtapid 5 mg capsules label showing the drug name with active ingredient lomitapide. The label indicates a package size of 28 capsules and includes storage instructions (20°C to 25°C, with excursions allowed between 15°C and 30°C). It is manufactured for Chiesi Farmaceutici S.p.A., Parma, Italy, and notes that it is Rx only with a reminder to dispense the medication guide.*

FDA Label Image

5 mg Carton Label (Juxtapid 07)

Juxtapid (lomitapide) 5 mg capsules packaging label for oral use. The label includes directions to see package insert for dosage and use, active ingredient lomitapide, and storage instructions (20°C to 25°C, with permitted excursions). The package contains 28 capsules and is marked Rx Only. Manufactured for Chiesi Farmaceutici S.p.A., Parma, Italy, with Chiesi USA, Inc. as labeler.*

FDA Label Image

10 mg Bottle Label (Juxtapid 08)

Juxtapid 10 mg capsules label by Chiesi USA, Inc., containing lomitapide mesylate. The label states the NDC 10122-410-28 and package count of 28 capsules. Storage instructions specify 20°C to 25°C (68°F to 77°F), with permitted excursions between 15°C and 30°C (59°F and 86°F). Manufacturer is Chiesi Farmaceutici S.p.A., Parma, Italy. The label includes a barcode and Rx only designation.*

FDA Label Image

10 mg Carton Label (Juxtapid 09)

Juxtapid 10 mg capsules packaging label for oral use, containing lomitapide mesylate as the active ingredient. The carton displays the proprietary name Juxtapid with the strength 10 mg prominently on an orange band, includes the Chiesi logo, and notes that the package contains 28 capsules. Storage instructions and manufacturer details (Chiesi Farmaceutici S.p.A., Parma, Italy) are visible, along with a note to see the package insert for dosage and use information.*

FDA Label Image

20 mg Bottle Label (Juxtapid 10)

Juxtapid 30 mg capsules packaging label showing the brand name Juxtapid (lomitapide) with a dosage strength of 30 mg. The label indicates the product is manufactured by Chiesi USA, Inc. and displays storage instructions and active ingredient information on a foldable carton design. The package contains 28 capsules and is labeled Rx Only.*

FDA Label Image

20 mg Carton Label (Juxtapid 11)

Juxtapid 20 mg capsules packaging label by Chiesi USA, Inc. The label indicates the active ingredient as lomitapide with each capsule containing 20 mg. The box contains 28 capsules and is marked Rx Only. Storage instructions include keeping the container tightly closed and protected from moisture, with temperature guidelines from 20°C to 25°C, allowing excursions between 15°C and 30°C. The label includes warnings to keep out of reach of children and pharmacist instructions to dispense the accompanying medication guide.*

FDA Label Image

30 mg Bottle Label (Juxtapid 12)

Label for Juxtapid (lomitapide) capsules, 30 mg strength, containing 28 capsules per package. The label includes storage instructions, manufacturer information (Chiesi Farmaceutici S.p.A., Parma, Italy), and a barcode with NDC 10122-430-28. The product is labeled Rx only with directions to see the package insert for dosage and use.*

FDA Label Image

30 mg Carton Label (Juxtapid 13)

Juxtapid 30 mg capsules packaging label featuring the brand name and dosage strength prominently. The active ingredient lomitapide is noted, with storage instructions and manufacturer listed as Chiesi Farmaceutici S.p.A., Parma, Italy. The label also indicates the package contains 28 capsules and is Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.